ACR Meeting Abstracts
Abstract Number: 3114 • ACR/ARHP Annual Meeting 2015
Mark C. Genovese1, Atsushi Ogata2, Akira Nomura3, Min Bao4, Elena Hitraya4, Stuart Lacey5 and Gerd Burmester6, 1Division of Rheumatology, Stanford University Medical Center, Palo Alto, CA, 2Osaka University Graduate School of Medicine and NTT West Osaka Hospital, Osaka, Japan, 3Chugai Pharmaceutical Co Ltd, Tokyo, Japan, 4Genentech, South San Francisco, CA, 5Roche, Welwyn Garden City, United Kingdom, 6Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany
Background/Purpose: Intravenous (IV) and subcutaneous (SC) formulations of tocilizumab (TCZ) are available for treatment of adult RA based upon the efficacy and safety outcomes of…